mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.4 |